29:43

Expert Perspectives: JAK Inhibitors in Myeloproliferative Neoplasms

HMP Education

23:34

Is there a role for JAK inhibitors in Essential Thrombocythemia (ET)?

HMP Education

17:25

Case study: Inadequately controlled Polycythemia Vera (PV)

HMP Education

19:52

Treatment option for Cytopenic Myelofibrosis (MF)

HMP Education